FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
ETF Building Blocks ChannelHow Increased FDA Activity Can Benefit ETFs in Your PortfolioBy Tom LydonNovember 19, 2020
Beyond Basic Beta ChannelBullish on Biotech? The BBH ETF is Not Just a 2020 PlayBy Ben HernandezNovember 18, 2020
Equity ETF ChannelBiotech ETFs Poised for Gains after Moderna Vaccine NewsBy Ian YoungNovember 16, 2020
ETF Building Blocks ChannelMore than Just COVID: Hot ETFs for Medical BreakthroughsBy Tom LydonNovember 5, 2020
Beyond Basic Beta ChannelCan’t Get Enough Biotech Exposure in Your Portfolio?By Ben HernandezOctober 29, 2020
ETF Building Blocks ChannelPost-Election Considerations for a Nifty Biotech ETFBy Tom LydonOctober 7, 2020
ETF Building Blocks ChannelA Healthcare ETF Could Benefit From Index ReshufflingBy Tom LydonJune 23, 2020
